Armistice Capital
North America, New York, United States, New York
Description
Armistice Capital is a global, value-oriented and event-driven hedge fund focused primarily on the health care and consumer sector.
Investor Profile
Armistice Capital has made 28 investments, with 5 in the past 12 months and 29% as lead.
Stage Focus
- Post Ipo Equity (96%)
- Post Ipo Debt (4%)
Country Focus
- United States (68%)
- France (11%)
- Switzerland (4%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (4%)
- Belgium (4%)
- Israel (4%)
- Germany (4%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Medical
- Biopharma
- Medical Device
- Genetics
- Manufacturing
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
